Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Chronic Myeloid Leukemia - Causes Of Treatment Failure With Imatinib [leucemia Mielóide Crônica - Causas De Falha Do Tratamento Com Mesilato De Imatinibe]
Author: Pagnano K.B.B.
Abstract: Imatinib is currently the treatment of choice of CML, but despite of the excellent results, it is not able to completely eradicate the disease and resistance may occur. The most studied mechanism is the presence of ABL kinase mutations that interfere with imatinib binding and action, gene amplification and clonal evolution. However, there are other mechanisms involved and less studied such as drug absorption and influx and efflux of imatinib. Besides the true causes of resistance, compliance is always a concern and also drug interaction should be checked. An understanding of these mechanisms will certainly contribute to develop new strategies for the treatment of resistant cases.
Rights: aberto
Identifier DOI: 10.1590/S1516-84842008000500007
Date Issue: 2008
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
2-s2.0-55949121628.pdf180.8 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.